NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles
NYU Langone Medical Center will lead a five-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and permanently affect the eye.